Literature DB >> 16982903

Fatal recall responses mediated by CD8 T cells during intracellular bacterial challenge infection.

Constantine Bitsaktsis1, Gary Winslow.   

Abstract

The roles(s) of CD8 T cells during infections by intracellular bacteria that reside in host cell endocytic compartments are not well understood. Our previous studies in a mouse model of human monocytotropic ehrlichiosis indicated that CD8 T cells are not essential for immunity. However, we have observed an unexpected role for these cells during challenge infection. Although immunocompetent mice cleared a primary low-dose (nonfatal) Ixodes ovatus ehrlichia infection, a secondary low-dose challenge infection resulted in fatal disease and loss of control of infection. The outcome was CD8-dependent, because CD8-deficient mice survived secondary low-dose challenge infection. Moreover, effector and/or memory phenotype CD8 T cells were responsible, because adoptive transfer of purified CD44(high) CD8 T cells to naive mice induced fatal responses following a primary low-dose infection. The fatal responses were perforin- and Fas ligand-independent, and were associated with high serum concentrations of TNF-alpha and CCL2, and low levels of IL-10. Accordingly, blockade of either TNF-alpha or CCL2 ameliorated fatal recall responses, and in vitro coculture of memory CD8 T cells and Ixodes ovatus ehrlichia-infected peritoneal exudate cells resulted in substantial increases in TNF-alpha and CCL2. Thus, during monocytotropic ehrlichiosis, inflammatory cytokine production, by CD8 T cells and/or other host cells, can trigger chemokine-dependent disease. These findings highlight a novel role for CD8 T cells, and reveal that live vaccines for intracellular bacteria can, under some conditions, induce undesirable consequences.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982903     DOI: 10.4049/jimmunol.177.7.4644

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies.

Authors:  Jere W McBride; David H Walker
Journal:  Expert Rev Mol Med       Date:  2011-01-31       Impact factor: 5.600

2.  Antigen display, T-cell activation, and immune evasion during acute and chronic ehrlichiosis.

Authors:  Bisweswar Nandi; Madhumouli Chatterjee; Kathryn Hogle; Maura McLaughlin; Katherine MacNamara; Rachael Racine; Gary M Winslow
Journal:  Infect Immun       Date:  2009-07-27       Impact factor: 3.441

3.  Ixodes ovatus Ehrlichia exhibits unique ultrastructural characteristics in mammalian endothelial and tick-derived cells.

Authors:  Ulrike G Munderloh; David J Silverman; Katherine C MacNamara; Gilbert G Ahlstrand; Madhumouli Chatterjee; Gary M Winslow
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

4.  The interaction between IL-18 and IL-18 receptor limits the magnitude of protective immunity and enhances pathogenic responses following infection with intracellular bacteria.

Authors:  Purnima Ghose; Asim Q Ali; Rong Fang; Digna Forbes; Billy Ballard; Nahed Ismail
Journal:  J Immunol       Date:  2011-06-29       Impact factor: 5.422

Review 5.  CD11c+ T-bet+ memory B cells: Immune maintenance during chronic infection and inflammation?

Authors:  Gary M Winslow; Amber M Papillion; Kevin J Kenderes; Russell C Levack
Journal:  Cell Immunol       Date:  2017-07-19       Impact factor: 4.868

Review 6.  New insights into molecular Ehrlichia chaffeensis-host interactions.

Authors:  Abdul Wakeel; Bing Zhu; Xue-Jie Yu; Jere W McBride
Journal:  Microbes Infect       Date:  2010-01-29       Impact factor: 2.700

7.  Natural killer cells promote tissue injury and systemic inflammatory responses during fatal Ehrlichia-induced toxic shock-like syndrome.

Authors:  Heather L Stevenson; Mark D Estes; Nagaraja R Thirumalapura; David H Walker; Nahed Ismail
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

8.  Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge.

Authors:  Nagaraja R Thirumalapura; Heather L Stevenson; David H Walker; Nahed Ismail
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

9.  T-Cell-independent humoral immunity is sufficient for protection against fatal intracellular ehrlichia infection.

Authors:  Constantine Bitsaktsis; Bisweswar Nandi; Rachael Racine; Katherine C MacNamara; Gary Winslow
Journal:  Infect Immun       Date:  2007-07-30       Impact factor: 3.441

10.  Nuclear translocated Ehrlichia chaffeensis ankyrin protein interacts with a specific adenine-rich motif of host promoter and intronic Alu elements.

Authors:  Bing Zhu; Kimberly A Nethery; Jeeba A Kuriakose; Abdul Wakeel; Xiaofeng Zhang; Jere W McBride
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.